Zydus Lifesciences gets EIR for Pre-Approval Inspection at manufacturing facility in Moraiya

11 May 2023 Evaluate

Zydus Lifesciences has received the Establishment Inspection Report (EIR) from the from the United States Food and Drug Administration (USFDA) for the inspection conducted at the manufacturing facility of the company located at Moraiya, Ahmedabad from January 23, 2023 to January 27, 2023. The inspection was a Pre-Approval Inspection (PAI) for Transdermal Patch products. The Audit had ended with NIL observations.  

Zydus Lifesciences (formerly known as Cadila Healthcare) is an India-based pharmaceutical company.


Zydus Lifesciences Share Price

881.10 13.30 (1.53%)
19-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1673.55
Dr. Reddys Lab 1166.45
Cipla 1391.20
Zydus Lifesciences 881.10
Lupin 2178.20
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×